Acutaas Chemicals Share Price | Acutaas Chemicals Stock Screener
ACUTAAS
Pharmaceuticals
Share Price NSE
₹3000.60
▼
-34.20 (-1.13%)
Share Price BSE
₹3002.00
▼
-30.15 (-0.99%)
As of May 27, 2026, the Acutaas Chemicals share price (NSE: ACUTAAS) is ₹3,000.60 on NSE and ₹3,002.00 on BSE, down 1.13% from the previous close, with shares trading between ₹2,989.00 and ₹3,075.30, and a 52-week range of ₹1,086.40–₹3,034.80.
Check ACUTAAS 52-week chart for the annual price range and momentum.
Use the Acutaas Chemicals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Acutaas Chemicals Market Cap
₹24,846.25 Cr.
ACUTAAS P/E Ratio (TTM)
67.74
Acutaas Chemicals P/B Ratio
14.46
EPS (TTM)
₹43.51
Dividend Yield
0.08%
Debt to Equity
0.12
ACUTAAS 52 Week High
₹3034.80
Acutaas Chemicals 52 Week Low
₹1086.40
Operating Margin
42.00%
Profit Margin
30.18%
ACUTAAS Revenue (TTM)
₹444.00
EBITDA
₹195.00
Net Income
₹134.00
Total Assets
₹1,984.00
Total Equity
₹1,654.00
Acutaas Chemicals Share Price Chart
Screen Acutaas Chemicals share price with an interactive chart. Analyse ACUTAAS price trends and volatility across different timeframes.
Acutaas Chemicals Company Profile - Fundamental Screener
Screen Acutaas Chemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ACUTAAS shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE00FF01025
Acutaas Chemicals Balance Sheet Screener
Screen ACUTAAS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 1,984 | 1,549 | 1,096 | 767 | 659 | 413 | 232 | 213 |
| Current Assets | 881 | 792 | 493 | 457 | 430 | 216 | 121 | 124 |
| Fixed Assets | 973 | 570 | 427 | 259 | 205 | 186 | 85 | 79 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 42 | 27 | 128 | 10 | 7 | 80 | 26 | 25 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 1,654 | 1,320 | 683 | 594 | 522 | 167 | 112 | 82 |
| Share Capital | 41 | 41 | 37 | 36 | 36 | 32 | 11 | 11 |
| Reserves & Surplus | 1,613 | 1,269 | 637 | 558 | 486 | 135 | 101 | 72 |
Acutaas Chemicals Income Statement Screener - Profit & Revenue Analysis
Screen Acutaas Chemicals income statement and profit fundamentals.
Analyze ACUTAAS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Acutaas Chemicals share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 444 | 314 | 223 | 316 | 398 | 226 | 178 | 255 | 277 | 186 | 155 | 174 | 170 | 144 | 132 |
| Expenses | 249 | 224 | 156 | 211 | 243 | 182 | 147 | 198 | 206 | 146 | 120 | 179 | 140 | 118 | 108 |
| EBITDA | 195 | 91 | 67 | 105 | 155 | 44 | 31 | 57 | 70 | 41 | 35 | -5 | 30 | 26 | 24 |
| Operating Profit % | 42.00% | 28.00% | 25.00% | 31.00% | 38.00% | 19.00% | 17.00% | 20.00% | 25.00% | 22.00% | 22.00% | -4.00% | 16.00% | 18.00% | 18.00% |
| Depreciation | 10 | 7 | 8 | 8 | 10 | 5 | 6 | 7 | 6 | 3 | 4 | 4 | 4 | 3 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 0 |
| Profit Before Tax | 184 | 83 | 58 | 96 | 145 | 37 | 20 | 50 | 63 | 37 | 31 | -10 | 24 | 22 | 20 |
| Tax | 50 | 20 | 14 | 24 | 38 | 12 | 5 | 13 | 18 | 10 | 9 | 7 | 6 | 1 | 6 |
| Net Profit | 134 | 63 | 44 | 72 | 106 | 26 | 15 | 38 | 46 | 27 | 22 | -17 | 18 | 21 | 15 |
| EPS | 16.09 | 7.80 | 5.41 | 8.82 | 13.19 | 6.85 | 3.67 | 9.38 | 11.35 | 7.47 | 4.57 | -4.67 | 4.83 | 6.22 | 4.08 |
Acutaas Chemicals Cash Flow Screener - Liquidity Fundamentals
Screen ACUTAAS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 118 | 125 | 66 | -12 | 28 | 27 | 15 | 9 | 29 | 10 |
| Investing Activities | -224 | -365 | -33 | -121 | -101 | -24 | -21 | -25 | -19 | -14 |
| Financing Activities | 261 | 239 | -12 | 140 | 72 | 0 | 6 | 15 | -7 | 4 |
| Net Cash Flow | 156 | -1 | 20 | 8 | -1 | 3 | 0 | -2 | 3 | 0 |
Acutaas Chemicals Shareholding Pattern Screener
See Acutaas Chemicals shareholding pattern with promoter, FII, and DII holdings.
Check Acutaas Chemicals promoter holding and ownership changes for ACUTAAS on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-May | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 32.66% | 35.96% | 32.66% | 32.66% | 32.66% | 39.91% | 39.07% | 35.98% |
| FII Holding | 19.48% | 16.48% | 16.94% | 16.85% | 16.67% | 8.97% | 10.01% | 12.92% |
| DII Holding | 19.60% | 18.31% | 22.38% | 22.59% | 21.70% | 6.81% | 8.81% | 14.81% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.21% | 24.19% | 23.27% | 22.79% | 23.53% | 30.01% | 28.79% | 26.06% |
| Other Holding | 5.03% | 5.05% | 4.74% | 5.10% | 5.43% | 14.30% | 13.33% | 10.22% |
| Shareholder Count | 112,939 | 114,060 | 119,890 | 108,664 | 110,363 | 95,784 | 92,721 | 90,329 |
Acutaas Chemicals Share Dividend Screener - Share Yield Analysis
Check Acutaas Chemicals dividend history with payout and yield data.
View Acutaas Chemicals dividend details including ex-dates and amounts for ACUTAAS stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.50 | 0.06% |
| 2024-March | ₹3.00 | 0.25% |
| 2023-March | ₹3.00 | 0.55% |
| 2022-March | ₹3.00 | 0.67% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Acutaas Chemicals Stock Index Membership
See which indices include Acutaas Chemicals stock.
Check ACUTAAS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Acutaas Chemicals Market Events Screener - Corporate Actions
Get Acutaas Chemicals corporate actions including splits, bonuses, and buybacks.
Check Acutaas Chemicals stock events that may affect ACUTAAS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.50 /share | 30.23% | ||
| Dividend | ₹ 3.00 /share | 22.46% | ||
| Dividend | ₹ 3.00 /share | 22.35% | ||
| Annual General Meeting | NA | 11.27% | ||
| Annual General Meeting | NA | 2.54% | ||
| 2026-04-30 | 2026-04-30 | Quarterly Result Announcement | NA | 4.41% |
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | 6.40% |
| 2025-10-17 | 2025-10-17 | Quarterly Result Announcement | NA | 9.21% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | -1.68% |
| 2025-05-10 | 2025-05-10 | Extraordinary General Meeting | NA | -1.28% |
| 2025-05-02 | 2025-05-02 | Quarterly Result Announcement | NA | 2.71% |
| 2025-04-25 | 2025-02-22 | Split | 5:10 | 0.00% |
| 2025-04-16 | 2025-04-16 | Change Of Name | NA | 0.00% |
| 2025-01-28 | 2025-01-28 | Quarterly Result Announcement | NA | -3.43% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | 9.18% |
Acutaas Chemicals Competitors Screener - Peer Comparison
Screen ACUTAAS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,670 | 40.42 | 58,220 | 6.38% | 11,565 | 54.06 |
| Divis Laboratories | 179,271 | 73.73 | 10,560 | 8.73% | 2,520 | 57.07 |
| Torrent Pharmaceuticals | 150,679 | 66.80 | 13,753 | 19.18% | 2,028 | 56.43 |
| Cipla | 114,503 | 29.26 | 27,712 | -2.46% | 3,783 | 64.74 |
| Dr Reddys Laboratories | 110,832 | 26.24 | 33,593 | -0.44% | 3,998 | 56.54 |
| Zydus Life Science | 108,578 | 20.40 | 26,720 | 13.65% | 5,242 | 74.62 |
| Lupin | 103,566 | 19.46 | 27,488 | 19.98% | 5,345 | 45.18 |
| Mankind Pharma | 100,047 | 52.84 | 14,278 | 12.03% | 1,750 | 55.67 |
| Aurobindo Pharma | 84,867 | 24.29 | 33,385 | 3.21% | 3,376 | 52.40 |
| Laurus Labs | 74,171 | 81.46 | 6,813 | 21.03% | 884 | 80.00 |
Acutaas Chemicals Company Announcements - News Screener
Screen ACUTAAS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-06 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-01 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-04-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-04-30 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-30 | Corporate Action-Board approves Dividend | - |
| 2026-04-30 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-04-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-04-30 | Audited Standalone And Consolidated Financial Statement & Results For Fourth Quarter And Year Ended March 31 2026 | - |
| 2026-04-30 | Board Meeting Outcome for Outcome Of The Board Meeting Eld On April 30 2026 | - |
| 2026-04-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-04-27 | Corporate Action-Board to consider Dividend | - |
| 2026-04-27 | Board Meeting Intimation for Approval Of Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended March 31 2026 Scheduled On Thursday April 30 2026. | - |
| 2026-04-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-02 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-25 | Closure of Trading Window | - |
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |